Dear Colleagues,

On behalf of the Local Organizing Committee, we welcome you to participate in the 9th Biennial Canadian Conference on Ovarian Cancer Research taking place in Edmonton, Alberta, Canada from May 26-29, 2018.

This conference will bring together the entire spectrum of ovarian cancer researchers; with interests in discovery-based, translational, clinical and population-level research. This meeting will foster collaborations and will examine the problem of ovarian cancer from all angles. The conference is open worldwide to all researchers and clinicians working, or interested, in ovarian cancer. We particularly welcome trainees and will host a trainee day workshop, to be held on Saturday, May 26, 2018.

With this conference, we continue in the tradition of the conference series that started with the first Canadian Conference on Ovarian Cancer Research held in Ottawa in 2002. Since that time, there have been substantial discoveries and an evolution in our understanding of ovarian cancer – alternative origins, genomic instability, histotype-specific gene mutations, tumour heterogeneity and emerging therapies. As in previous conferences, we are developing a rigorous scientific program that introduces innovative ideas and highlights key nascent findings in ovarian cancer research.

In addition to a full scientific program of research symposia and poster sessions, the conference will be preceded by the highly-praised full-day trainee workshop that offers a unique opportunity for our young researchers to interact and learn the basics of this disease from faculty experts across Canada. In addition, a survivors workshop supported by Ovarian Cancer Canada takes place concurrently with the first day of the conference, providing a unique learning opportunity and supportive environment for survivors, family members, friends and caregivers.

Edmonton, the capital of Alberta is an exciting and dynamic city, boasting one of the largest green spaces in North America as well as a vibrant cultural scene. The Rocky Mountains are also within driving distance, providing an opportunity to embrace one of the world’s most beautiful locations. This conference promises to bring together the best minds in ovarian cancer research and to provide an outstanding educational and networking experience.

We hope you and your colleagues will join us for this exciting conference!

Lynne-Marie Postovit
PhD, University of Alberta
Helen Steed
MD, University of Alberta
Elisabeth Baugh
MHSc, Honorary Co-Chair, Chief Executive Officer, Ovarian Cancer Canada